Search
Drometrizole trisiloxane
go.drugbank.com/drugs/DB11585Approvedbeing generally recognized as safe and effective for over-the-counter sunscreen use [L2795, F82]. … The compound is a lipophilic benzotriazole derivative marketed as Meroxyl XL by L'Oreal, although sunscreens with drometrizole trisiloxane are currently only approved for use in the EU, Canada, Australia
Mixtures: Airyday Spf50+ Clear As Day Dreamscreen, Garnier Ombrelle SPF 30 Complete UVA UVB Sensitive Advanced Sunscreen for Sensitive Skin Hypoallergenic Non comedogenic Quick Absorption Water/sweat resistant 80 minutesMerbromin
go.drugbank.com/drugs/DB13392InvestigationalMercurochrome is a trade name of merbromin commonly used as a topical first-aid antiseptic agent.
Products: MERBROMINA NADabrafenib
go.drugbank.com/drugs/DB08912ApprovedInvestigationalIt was approved on May 29, 2013, for the treatment of melanoma with V600E or V6000K mutation.[L41955] It was also used for metastatic non-small cell lung cancer with the same mutation. … [L41955] In May 2018, Tafinlar (dabrafenib), in combination with Mekinist ([DB08911]), was approved to treat anaplastic thyroid cancer caused by an abnormal BRAF V600E gene.[L41955]
Ferric pyrophosphate
go.drugbank.com/drugs/DB09147ApprovedInvestigationalThe ferric ion is strongly complexed by pyrophosphate.[A31979] It presents an increasing interest as this insoluble form can be milder in the gastrointestinal tract and present higher bioavailability.
2,6-anhydro-3-deoxy-3-fluoronononic acid
go.drugbank.com/drugs/DB04694ExperimentalSynonyms: 3-deoxy-3-fluoro-D-erythro-α-L-manno-non-2-ulopyranosonic acidLoxoprofen
go.drugbank.com/drugs/DB09212ApprovedInvestigationalIt is marketed under the trade name Loxonin in Brazil, Mexico and Japan by Sankyo, as Loxomac in India, and as Oxeno in Argentina. … Loxoprofen is a propionic acid derivative non-steroidal anti-inflammatory drug.
Categories: Analgesics, Non-Narcotic, Non COX-2 selective NSAIDSLysine
go.drugbank.com/drugs/DB00123ApprovedInvestigationalNutraceuticalCollagen contains hydroxylysine which is derived from lysine by lysyl hydroxylase.
Mixtures: ONE A DAY TABLET, SmofKabiven Low Osmo peripher Emulsion zur InfusionRiltozinameran
go.drugbank.com/drugs/DB17095ApprovedInvestigational[L43922] It tends to cause less severe disease but is significantly more virulent than both the original virus and earlier variants (e.g. Delta). … It is administered in combination with [tozinameran] for active immunization against COVID-19 caused by SARS-CoV-2, including infection caused by Omicron BA.1[L45419]
Nicoboxil
go.drugbank.com/drugs/DB12911ApprovedWithdrawnNicoboxil has been investigated for the treatment of Acute Low Back Pain, where it is typically considered an effective and safe therapeutic option. … in the medication(s) given its demonstrated efficacy, safety, and capability to be used as an alternative musculoskeletal pain therapy option with less systemic side effects when compared to the oral non-steroidal
Plazomicin
go.drugbank.com/drugs/DB12615ApprovedHowever, acquired resistance of aminoglycosides may arise through over expression of efflux pumps and ribosomal modification by bacteria, which results from amino acid or rRNA sequence mutations [A33942 … Developed by Achaogen biopharmaceuticals, plazomicin is a next-generation aminoglycoside synthetically derived from [DB12604].